Robert Walczak
25Patents
6h-index
24Co-inventors
65Inventor score
Filing activity: Aug 26, 2009 → Oct 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD733322S1 | Hexagonally-shaped solar heating swimming pool cover | General | 16 | Active |
| US8131799B2 | User-transparent system for uniquely identifying network-distributed devices without explicitly provided device or user identifying information | Electricity | 15 | Active |
| US11590108B2 | Pharmaceutical compositions for combination therapy | Human Necessities | 7 | Active |
| US11478440B2 | Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent | Human Necessities | 7 | Active |
| US11484517B2 | Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor | Human Necessities | 7 | Active |
| US11974997B2 | RORgamma modulators and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US9902725B2 | Heterocyclic derivatives as RORgamma modulators | Chemistry; Metallurgy | 3 | Active |
| US10653678B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 2 | Active |
| US11033534B2 | Pharmaceutical compositions for combination therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US10130612B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US10905680B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US10117855B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US11191749B2 | Pharmaceutical compositions for combination therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US12053456B2 | Pharmaceutical compositions for combination therapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US10117856B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US10130613B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 1 | Active |
| US12208087B2 | Combination of nitazoxanide and elafibranor for the treatment of immune diseases or inflammation | Human Necessities | 0 | Active |
| US11160801B2 | RORgamma modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11052092B2 | N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US11077115B2 | Rorgamma modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10792277B2 | Methods of treatment of fibrosis and cancers | Human Necessities | 0 | Active |
| US10987351B2 | RORgamma modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12391712B2 | Phosphate derivatives of RORgamma modulators and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11400078B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 0 | Active |
| US11103484B2 | Methods of treatment for cholestatic and fibrotic diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.